| abstract |
The present invention relates to novel 1,2,4-oxadiazole derivatives. The derivative is an inhibitor of dipeptidyl peptidase-IV enzyme (“DP-IV inhibitor”) and is useful for the treatment or prevention of diseases involving dipeptidyl peptidase-IV enzyme such as diabetes, particularly type 2 diabetes. . The present invention relates to a pharmaceutical composition comprising a 1,2,4-oxadiazole derivative, and a 1,2,4-oxadiazole derivative in the prevention or treatment of a disease involving dipeptidyl peptidase-IV enzyme and the composition Also related to the use of. |